Voyageur Pharmaceuticals Ltd.
Voyageur Pharmaceuticals Confirms Pharmaceutical-Grade Purity of Barite from Frances Creek and Progresses to Health Canada Human Trial with Alberta Innovates Grant; Announces Stock Option and DSU grants, and Proposed Issuance of Securities for Debt
Voyageur Pharmaceuticals has confirmed that its Frances Creek barite achieves pharmaceutical-grade purity, with average BaSO4 levels of 98.8%, exceeding USP requirements. The company is progressing toward Health Canada human trials and has secured support through the Alberta Innovates program.